Evo, a London, UK-based surgical and high-precision engineering company that provides bespoke full jaw dental implant solutions in one day to patients, received a £4m in funding.
BGF made the investment who was led by George Tsangarides, Thomas McDonnell and Alistair Brew (who joins the Board of the company).
The funding will be used to expand capacity at Evo’s current facilities, rollout new clinics in the UK and explore franchise opportunities internationally.
Led by founder Dr R.P. Vijayanarayanan BDS, Evo provides an advanced, proprietary solution for patients suffering from severe dental problems caused by advanced gum disease, congenital bone loss or accidents, and who require a full jaw reconstruction. The company’s process features digital scanning, prosthesis manufacturing, 3D printing, and high-precision milling machines with an accuracy of below ten microns – which is on par with aerospace engineering.
The business has centres in Heathrow and Liverpool, and has completed more than 3,000 full-arch reconstructions.
Michael Lewis, who has held senior roles in growing businesses in the healthcare and medical devices sectors including Align Technologies, Cambridge Cognition, Glyconics and iPlato, has been appointed as Non-Executive Chairman.